Pregnane X receptor activation constrains mucosal NF-κB activity in active inflammatory bowel disease

Autor: Sunrui Chen, Meng Li, J. Jasper Deuring, Wenshi Wang, Colin de Haar, C. Janneke van der Woude, Wanlu Cao, Maikel P. Peppelenbosch
Přispěvatelé: Gastroenterology & Hepatology
Jazyk: angličtina
Rok vydání: 2019
Předmět:
0301 basic medicine
Biopsy
Cell Lines
Gene Expression
Pathology and Laboratory Medicine
Inflammatory bowel disease
chemistry.chemical_compound
0302 clinical medicine
Gene expression
Medicine and Health Sciences
Organ Cultures
Intestinal Mucosa
Immune Response
Pregnane X receptor
Multidisciplinary
medicine.diagnostic_test
NF-kappa B
Pregnane X Receptor
Organoids
Medicine
Cytokines
030211 gastroenterology & hepatology
Biological Cultures
Signal transduction
Anatomy
Rifampin
Research Article
Signal Transduction
Colon
Science
Immunology
Surgical and Invasive Medical Procedures
Gastroenterology and Hepatology
Research and Analysis Methods
digestive system
03 medical and health sciences
Signs and Symptoms
Western blot
Diagnostic Medicine
Cell Line
Tumor

medicine
Genetics
Humans
Inflammation
business.industry
Inflammatory Bowel Disease
Biology and Life Sciences
NF-κB
medicine.disease
Inflammatory Bowel Diseases
digestive system diseases
Gastrointestinal Tract
030104 developmental biology
chemistry
Caco-2
Cell culture
Cancer research
Caco-2 Cells
business
Digestive System
Zdroj: PLoS ONE
PLoS ONE, Vol 14, Iss 10, p e0221924 (2019)
PLoS One (print), 14(10):e0221924. Public Library of Science
ISSN: 1932-6203
Popis: Background The Pregnane X Receptor (PXR) is a principal signal transducer in mucosal responses to xenobiotic stress. It is well-recognized that inflammatory bowel disease is accompanied by xenobiotic stress, but the importance of the PXR in limiting inflammatory responses in inflammatory bowel disease remains obscure at best. Methods We stimulate a total of 106 colonic biopsies from 19 Crohn’s disease patients with active disease, 36 colonic biopsies from 8 control patients, colonic organoids and various cell culture models (either proficient or genetically deficient with respect to PXR) in vitro with the PXR ligand rifampicin or vehicle. Effects on NF-κB activity are assessed by measuring interleukin-8 (IL-8) and interleukin-1s (IL-1s) mRNA levels by qPCR and in cell culture models by NF-κB reporter-driven luciferase activity and Western blot for signal transduction elements. Results We observe a strict inverse correlation between colonic epithelial PXR levels and NF-κB target gene expression in colonic biopsies from Crohn’s disease patients. PXR, activated by rifampicin, is rate-limiting for mucosal NF-κB activation in IBD. The correlation between colonic epithelial PXR levels and NF-κB target gene expression was also observed in intestinal organoids system. Furthermore, in preclinical in vitro models of intestinal inflammation, including intestinal organoids, genetic inactivation of PXR unleashes NF-κB-dependent signal transduction whereas conversely NF-κB signaling reduces levels of PXR expression. Conclusions Our data indicate that the PXR is a major and clinically relevant antagonist of NF-κB activity in the intestinal epithelial compartment during inflammatory bowel disease.
Databáze: OpenAIRE
Nepřihlášeným uživatelům se plný text nezobrazuje